Related Experiment Video
Updated: Aug 13, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin
S M Newton1, M Kotb, T P Poirier
1Department of Microbiology and Immunology, Stanford University School of Medicine, California 94305.
Abstract:
A synthetic 48-bp oligonucleotide specifying the N-terminal 15 amino acids of M protein of Streptococcus pyogenes type 5 (plus a CTA codon, to terminate translation of genes with the insert in reverse orientation) was inserted by blunt-end ligation at the site of the 48-bp EcoRV deletion in the Salmonella flagellin gene in plasmid pLS408 (S. M. C. Newton, C. O. Jacob, and B. A. D. Stocker, Science 244: 70-72, 1989). The resulting plasmid was transferred from Escherichia coli via a restriction-negative Salmonella typhimurium strain into an aromatic-compound-dependent, flagellin-negative live-vaccine strain of Salmonella dublin to produce strain SL7127, which was motile. Expression of the inserted epitope in flagellin and its exposure at the flagellar filament surface were shown by immunoblotting and by the reaction of flagellate bacteria (immobilization, immunogold labeling) with antibody raised by injection of the corresponding synthetic peptide, S-M5(1-15). Rabbits immunized by injection of the live-vaccine strain with flagella composed of the chimeric flagellin or by injection of concentrated flagella from such bacteria developed antibodies reactive in an enzyme-linked immunosorbent assay with peptide S-M5(1-15) and with the large peptic-digest peptide pepM5. These antibodies were opsonic for type 5 streptococci. Mice that were given parenteral live SL7127 (six doses, each 1 x 10(6) to 2 x 10(6), over 8 weeks) developed titers of ca. 12,800 for the M5-specific peptides and opsonizing activity for type 5 streptococci but not for type 24 streptococci. Sera from mice similarly immunized with a control live vaccine strain without an insert in the flagellin gene did not react with the M5-specific antigens. All of the five mice given the control strain, without an insert, died after challenge with type 5 streptococci or type 24 streptococci; by contrast, four of the five mice given strain SL7127, with an insert, survived the M5 challenge, but none of the five challenged with the type 24 strain survived. Therefore, our study shows that an M protein epitope can be expressed in the context of an unrelated protein and maintain its immunogenicity. Furthermore, we demonstrate that mice can be protected against a Streptococcus pyogenes type 5 challenge by immunization with a Salmonella live vaccine with flagella made of flagellin with an insert carrying a protective epitope of M5 protein but without the cross-reactive epitopes of the complete protein.
Insights
This study engineered a Salmonella vaccine to express a Streptococcus pyogenes M protein epitope on its flagella. This chimeric vaccine successfully elicited protective immunity against type 5 Streptococcus pyogenes in mice.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Streptococcus pyogenes M protein is crucial for virulence and a target for protective immunity.
- Developing effective vaccines against Streptococcus pyogenes remains a challenge.
- Heterologous protein expression in bacterial flagella offers a novel vaccine delivery strategy.
Purpose of the Study:
- To engineer a live Salmonella vaccine expressing a Streptococcus pyogenes M protein epitope.
- To evaluate the immunogenicity and protective efficacy of the engineered vaccine.
Main Methods:
- A synthetic oligonucleotide encoding the M protein epitope was inserted into the Salmonella flagellin gene.
- The modified Salmonella strain was used to immunize mice.
- Immunogenicity was assessed by antibody titers and opsonization assays.
- Protective efficacy was determined by challenge experiments with Streptococcus pyogenes.
Main Results:
- The engineered Salmonella vaccine successfully expressed the M protein epitope on its flagella.
- Immunization induced high titers of M protein-specific antibodies and opsonizing antibodies.
- Mice immunized with the engineered vaccine showed significant protection against Streptococcus pyogenes type 5 challenge.
Conclusions:
- An M protein epitope can be expressed in an unrelated protein (flagellin) while retaining immunogenicity.
- A live Salmonella vaccine displaying a Streptococcus pyogenes M protein epitope can confer protection against infection.
- This approach represents a promising strategy for developing novel vaccines against bacterial pathogens.

